Russia still using chemical weapons in battle, experts say

Russian forces have reportedly used hazardous chemical agents in Ukraine more than 9,000 times since the invasion, including 6,540 incidents last year involving CS/CN riot-control gases and instances of World War I-era chloropicrin; the OPCW has confirmed toxic agents in frontline samples and the EU has imposed sanctions. Western intelligence and investigations (including Bellingcat) allege continued Russian chemical-weapons research (notably novichok) despite declared stockpile destruction, raising escalation and sanction risks that could prompt further geopolitical-driven market moves—notably in defense, European risk assets and energy-related exposures.

Analysis

Market structure: Immediate winners are defense primes (air‑defense, ISR, CBRN gear), tactical drone and protective‑equipment suppliers, and upstream oil/gas producers if sanctions disrupt supplies. Losers are Russian assets, EM credits exposed to Russia, European importers of Russian gas, and insurers/reinsurers facing new claim clusters; pricing power shifts to large primes (LMT, RTX, NOC) and niche CBRN vendors (MSA) as procurement budgets rise. Cross‑asset: expect safe‑haven bond bids (core yields -10–30bp intraday), gold +3–6% on shocks, oil/gas spikes (WTI +10–25% on supply risk), RUB depreciation >10% on sanctions, and option vols up in energy/defense sectors.

Risk assessment: Tail risks include a confirmed large‑scale use of lethal CW prompting EU/US energy embargoes and Russian financial exclusion—scenario could push Brent >$120/bbl and trigger 1970s‑style inflation shocks; probability low but impact asymmetric. Timeframes: days = risk‑off and volatility spikes; weeks–months = procurement orders and defense re‑rating; 12–36 months = structural EU/NATO budget uplift (estimate +10–30% capex). Hidden dependencies: defense supply chains (semiconductors, rare earths) and export control frictions may bottleneck delivery, capping revenue realization.

Trade implications: Favor allocated exposure to large defense primes and niche CBRN PPE makers, overweight energy producers as insurance against supply loss, and buy gold/long sovereign core bonds as tail hedges. Use options to express convexity—buy LEAP calls on defense names and oil call spreads to cap cost; hedge via puts on European equities or small short exposure to Russia proxies (RSX). Entry: deploy on volatility spikes; scale over 4–12 weeks.

Contrarian angles: Consensus assumes permanent high defense multiples; risk that rapid diplomatic de‑escalation or logistical bottlenecks (supply chain) leave order books unfilled—defense equities could mean‑revert 15–25% if growth disappoints. Underfollowed winners include pure‑play CBRN detection/protection (MSA ticker MSA) which may rerate less quickly; use spread trades (long niche CBRN, short large diversified contractor) to capture repricing asymmetry.

Key Decisions for Investors

• Establish a 3% net long allocation to aerospace & defense: buy LMT and RTX equal weight (1.5% each) and simultaneously purchase 12‑18 month LEAP calls (approx 10% OTM) sized at 0.5% notional to add convex upside; target +25–40% in 12 months, stop‑loss 15%.
• Allocate 1.5% to CBRN/personal‑protective names: buy MSA (MSA) 1% and HON 0.5%; target 30% upside in 6–12 months as procurement ramps; trim if order flow misses expectations or if government capex guidance unchanged after 6 months.
• Purchase a tactical oil hedge: buy a Dec‑2025 WTI $90/$120 call spread sized to 1% portfolio notional (cost‑limited exposure) to capture upside if supply sanctions push Brent >$100; unwind if front‑month WTI closes below $75 for 30 consecutive trading days.
• Buy 2% allocation to GLD (or 3‑month gold calls) and increase core sovereign long duration by 1–2% (e.g., 10‑year Bund/UST exposure) as immediate tail‑risk hedges; reduce within 4–8 weeks if geopolitical premium compresses >50%.
• Implement a pair: go long LMT (0.75%) and short VanEck Russia ETF RSX (0.5%) to express asymmetric geopolitical risk; close the short if RSX rallies >25% or if major diplomatic de‑escalation occurs (verified by EU/US sanctions rollback within 30 days).